期刊文献+

急性冠状动脉综合征经皮冠状动脉介入治疗中无复流现象的处理 被引量:4

The treatment of No-Reflow phenomena in ACS emergency PCI operations
原文传递
导出
摘要 目的 分析急性冠状动脉综合征 (ACS)患者急诊经皮冠状动脉介入治疗 (PCI)术中无复流 (No Reflow)现象的原因、处理。方法 对 2 0 0 1- 0 6~ 2 0 0 3- 10经治的 72例ACS急诊PCI术中No -Reflow现象的冠状动脉的特点、可能原因、紧急处理及 1~ 2 8个月的结果进行分析。结果  1例术后 4h死于反复室颤 ,1例术后 76h死于心力衰竭 ,5例术中出现急性冠脉闭塞表现 ,经过冠状动脉内注射合心爽、硝酸甘油、IABP后好转 ,3例存活至今 ,1例术后 2 8个月死于脑干出血。结论 ACS患者急诊PCI术中出现No Reflow现象时 ,过程凶险 ,预后差 ,病死率高 ,治疗应首选联合应用冠状动脉内注射合心爽 (地尔硫 艹卓)、硝酸甘油或主动脉内球囊反搏 (IABP)。 Objective To analyze the cause of ACS (acute coronary syndrome) patients in emergency PCI (percutaneous coronary interventions) operations and treatment.Methods To study the characteristics of coronary artery,possible reason,emergency treatment and results of 1~28 months in 72 cases of ACS emergency PCI operations of No-Reflow phenomena which was between June 2001 and Oct 2003.Results One case died of repeated ventricular fibrillation 4 hours after the procedure one case died of heart failure 76 hours after the procedure and five cases showed acute coronary artery occlusion.By coronary injecting HERBESSER,nitroglycerin and IABP,the patients got better.Three of five are living now,one of them died of hemorrhage of brain stem 28 months after the procedure.Conclusion When ACS patients in emergency PCI operations show No-Reflow phenomena,the process is dangerous,the prognosis is bad,and the death rate is high,so we should first use HERBESSER together with nitroglycerin or IABP (intra-aortic balloon pump).
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2005年第1期63-64,共2页 Chinese Journal of Practical Internal Medicine
关键词 术中 经皮冠状动脉介入治疗 ACS 急性冠状动脉综合征 术后 IABP 合心爽 现象 结论 过程 Acute coronary syndrome No-Reflow Percutaneous coronary interventions Emergency
  • 相关文献

参考文献7

  • 1Leopold JA, Berger CJ, Cuppies LA, et al. No-reflow during coronary intervention: observations and implications. Circulation, 2000, 102(Suppl Ⅱ) : Ⅱ-644.
  • 2Wainstein M, Frederic F, Lee M, et al. Lack of clinical efficacy of pharmacologic treatment of no-flow phenomenon despite significant angiographic improvement. J Am Coll Cardiol,2001,37 (2):83A.
  • 3Sharma SK,Dangas G,Mehran R ,et al. Risk factors for the development of slow flow during rotational coronary atherectomy. Am J Cardiol, 1997 ,80(2) :219-222.
  • 4Erbel R, Heusch G. Coronary microembolization. J Am Coll Cardiol.2000,36( 1 ) :22-24.
  • 5H Richard H, Shereif HR, Robert AK. No-reflow phenomenon response. Circulation ,2002,106 ( 20 ) : 143.
  • 6Piana RN,Paik GY, Moscucci M, et al. Incidence and treatment of No-reflow after percutaneous coronary intervention. Circulation,1994,89(6) :2514--2518.
  • 7Wyrens F J, Mooney J, Lesser J,et al.Intracoronary diltiazem for microvascular spasm after interventional therapy. Am J Cardiol, 1995,75(12) :849-850.

同被引文献28

  • 1杨跃进.经皮冠状动脉介入治疗中无再流的诊断、治疗和预防[J].中华心血管病杂志,2004,32(7):662-664. 被引量:57
  • 2黄陆力,张永春.CTFC在急性心肌梗死PCI中的价值及腺苷干预的研究[J].中国医师杂志,2005,7(6):756-758. 被引量:2
  • 3贺晓楠,李淑梅,刘斌.应用腺苷救治成功PCI术无复流2例[J].中国老年学杂志,2006,26(6):826-827. 被引量:1
  • 4杨跃进,赵京林.急性心肌梗死再灌注治疗的现代观念[J].中国实用内科杂志,2006,26(8):1124-1128. 被引量:20
  • 5Dobrzycki S,Kozuch M,Kaminski K,et al.High cholesterol in patients with ECG signs of no reflow after myocardial infarction[J].Rocz Akad Med Bialymst,2003 ;48:118-22.
  • 6Desmet WJ,Dens J,Coussement P,et al.Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? ADELINE pilot trial.Adenosine limit myocardial necrosis[J].Heart,2002; 88(3):293-5.
  • 7Pasceri V,Pristipino C,Pelliccia F,et al.Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction[J].Am J Cardiol,2005,95 (11):1358-1361.
  • 8Mukherjee D,Oz M,Prager R,et al.Elective coronary revascularization,an iatrogenic form of acute coronary syndrome:how can clinicians reduce the risks?[J].Am Heart J,2004,148(3):371-377.
  • 9Pasceri V,Patti G,Di Sciascio G.Prevention of myocardial damage during coronary intervention[J].Cardiovasc Hematol Disord Drug Targets,2006,6 (2):77-83.
  • 10Cavallini C,Savonitto S,Violini R,et al.Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention:results of the CK-MB and PCI study[J].Eur Heart J,2005,26(15):1494-1498.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部